Keywords: vertex, pharmaceuticals, acquire, aurora, biosciences, million, deal
Vertex Pharmaceuticals to acquire Aurora Biosciences in $592 million deal
Article | 01 May 2001
Vertex Pharmaceuticals has entered into an agreement to acquire AuroraBiosciences Corp in a stock-for-stock transaction valued at approximately $592 million. The ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Highlights of EHA meeting: Novartis' Jakavi; Bristol-Myers and AbbVie's elotuzumab; Janssen's ibrutinib
- Osteoporosis drug bazedoxifene stops growth of breast cancer cells, even in resistant tumors
- InSite Vision joins Merck & Co and Pfizer in patent infringement law suit against
- Elan puts up formal "for sale" notice
- Additional indications in Japan for Roche's Avastin and Astellas' Prograf
